Polyvinylpyrrolidone-Capped Copper Oxide Nanoparticles-Anchored Pramipexole Attenuates the Rotenone-Induced Phenotypes in a Drosophila Parkinson’s Disease Model

Polyvinylpyrrolidone-Capped Copper Oxide Nanoparticles-Anchored Pramipexole Attenuates the Rotenone-Induced Phenotypes in a Drosophila Parkinson’s Disease Model

Bibliographic Details
Main Authors:	Ramesha Hanumanthappa, Deepa Mugudthi Venugopal, Nethravathi P C, Ahesanulla Shaikh, Siddaiah B.M, Geetha B. Heggannavar, Akshay A. Patil, Hemalatha Nanjaiah, D. Suresh, Mahadevappa Y. Kariduraganavar, Shamprasad Varija Raghu, Kuramkote Shivanna Devaraju
Format:	Article
Language:	English
Published:	American Chemical Society 2023-12-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.3c04312

Similar Items

A Comparative Study of Crystallography and Defect Structure of Corneal Nipple Array in Daphnis nerii Moth and Papilio polytes Butterfly Eye
by: Shamprasad Varija Raghu, et al.
Published: (2020-09-01)

Candidate glutamatergic neurons in the visual system of Drosophila.
by: Shamprasad Varija Raghu, et al.
Published: (2011-01-01)

Development of Doxorubicin-Loaded Magnetic Silica–Pluronic F‑127 Nanocarriers Conjugated with Transferrin for Treating Glioblastoma across the Blood–Brain Barrier Using an in Vitro Model
by: Geetha B. Heggannavar, et al.
Published: (2018-07-01)

Preserving neural function under extreme scaling.
by: Hermann Cuntz, et al.
Published: (2013-01-01)

Pramipexole use and the risk of pneumonia
by: Ernst Pierre, et al.
Published: (2012-09-01)

Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy
by: Shampa Ghosh, et al.
Published: (2021-04-01)

Pramipexole for the treatment of depression: efficacy and mechanisms
by: Halahakoon, DC, et al.
Published: (2023)

Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients
by: Müge Kuzu, et al.
Published: (2016-09-01)

The sterochemistry of rotenone
by: Kaltenbronn, James Stanley, 1934-
Published: (2022)

2,5-Bis(2,2,2-trifluoroethoxy)phenyl-tethered 1,3,4-Oxadiazoles Derivatives: Synthesis, In Silico Studies, and Biological Assessment as Potential Candidates for Anti-Cancer and Anti-Diabetic Agent
by: Sathyanarayana D. Shankara, et al.
Published: (2022-12-01)

Crosslinked Nanocomposite Sodium Alginate-Based Membranes with Titanium Dioxide for the Dehydration of Isopropanol by Pervaporation
by: H.G. Premakshi, et al.
Published: (2020-03-01)

Sustained-release pramipexole in the treatment of Parkinson’s disease
by: Natalia Vladimirovna Fedorova
Published: (2012-03-01)

Reinforcing properties of Pramipexole in normal and parkinsonian rats
by: Michel Engeln, et al.
Published: (2013-01-01)

Toxicological Profiling of Onion-Peel-Derived Mesoporous Carbon Nanospheres Using In Vivo <i>Drosophila melanogaster</i> Model
by: Vinay S. Bhat, et al.
Published: (2022-01-01)

Effects of pramipexole on the processing of rewarding and aversive taste stimuli.
by: Mccabe, C, et al.
Published: (2013)

Effects of pramipexole on the processing of rewarding and aversive taste stimuli
by: McCabe, C, et al.
Published: (2013)

Pramipexole enhances reward learning by preserving value estimates
by: Halahakoon, DC, et al.
Published: (2023)

High-degree atrioventricular heart block induced by pramipexole
by: Yücel Kanal, et al.
Published: (2022-02-01)

Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Pramipexole
by: Fettah EREN, et al.
Published: (2020-12-01)

Pramipexole and its Extended Release Formulation for Parkinson's Disease
by: Paul S. Fishman
Published: (2011-01-01)

Pramipexole and its Extended Release Formulation for Parkinson’s Disease
by: Paul S. Fishman
Published: (2011-06-01)

Effect of Venlafaxine, Pramipexole, and Valsartan on Spermatogenesis in Male Rats
by: Uzma Saleem, et al.
Published: (2020-08-01)

ANALYSIS POLYVINYLPYRROLIDONE IN DOSAGE FORMS
by: L. L. Nikolaeva, et al.
Published: (2016-09-01)

The Utility of Peptide Ligand-Functionalized Liposomes for Subcutaneous Drug Delivery for Arthritis Therapy
by: Hemalatha Nanjaiah, et al.
Published: (2023-04-01)

A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole
by: Ratih S. I. Putri, et al.
Published: (2016-11-01)

Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride
by: Mylien T. Hoang, et al.
Published: (2015-09-01)

Pramipexole impairs stimulus-response learning in healthy young adults
by: Haley Gallant, et al.
Published: (2016-08-01)

Factors Affecting the Efficacy of Pramipexole in Patients with Restless Legs Syndrome
by: Mohammad Rezvani, et al.
Published: (2013-06-01)

Factors Affecting the Efficacy of Pramipexole in Patients with Restless Legs Syndrome
by: Mohammad Rezvani, et al.
Published: (2013-06-01)

Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
by: Xue Qing Yang, et al.
Published: (2016-10-01)

Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
by: Filip Ventorp, et al.
Published: (2022-06-01)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
by: Radu Constantinescu
Published: (2008-04-01)

Pramipexole and tolcapone alleviate thermal and mechanical nociception in naive rats.
by: Anita Mihaylova, et al.
Published: (2021-06-01)

A zinc-finger fusion protein refines Gal4-defined neural circuits
by: Shamprasad Varija Raghu, et al.
Published: (2018-08-01)

Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease
by: D. Yu. Belousov, et al.
Published: (2018-05-01)

Optimization of Pramipexole-Loaded In Situ Thermosensitive Intranasal Gel for Parkinson’s Disease
by: Rushi Trivedi, et al.
Published: (2024-01-01)

The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting
by: Gabriele Floris, et al.
Published: (2022-04-01)

Molecular Docking Study of Pramipexole Derivatives as Radiopharmaceutical Candidates for Brain Imaging
by: Wibawa Teguh Hafiz Ambar, et al.
Published: (2024-01-01)

Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease
by: S N Illarioshkin
Published: (2012-06-01)

Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole
by: M. R. Nodel
Published: (2011-12-01)